Akihiko Okada Selected Research

Disseminated Intravascular Coagulation

2/2023	Clinical impact of recombinant thrombomodulin administration on disseminated intravascular coagulation due to severe acute cholangitis (Recover-AC study).
4/2019	Multicenter clinical experience with recombinant soluble thrombomodulin for disseminated intravascular coagulation associated with severe acute cholecystitis.
9/2015	Efficacy of recombinant human soluble thrombomodulin in preventing walled-off necrosis in severe acute pancreatitis patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Akihiko Okada Research Topics

Disease

3	Disseminated Intravascular Coagulation 02/2023 - 09/2015
3	Necrosis 09/2021 - 09/2015
3	Pancreatitis 09/2021 - 09/2015
2	Sepsis (Septicemia) 02/2023 - 04/2019
2	Constipation 01/2021 - 01/2021
2	Esophageal and Gastric Varices (Esophageal Varices) 12/2020 - 04/2020
2	Hemorrhage 12/2020 - 04/2020
2	Peptic Esophagitis (Reflux Esophagitis) 01/2019 - 01/2017
2	Gastroesophageal Reflux (GERD) 01/2019 - 01/2015
1	Cholangitis 02/2023
1	Polyps 05/2022
1	Atrophic Gastritis 01/2021
1	Neoplasms (Cancer) 12/2020
1	Anemia 12/2020
1	Pancreatic Neoplasms (Pancreatic Cancer) 09/2020
1	Cardiac Arrhythmias (Arrythmia) 04/2020
1	Varicose Veins (Varicose Vein) 04/2020
1	Esophageal Neoplasms (Esophageal Cancer) 04/2020
1	Acute Cholecystitis 04/2019
1	Non-Erosive Reflux Disease 01/2019
1	Heartburn (Pyrosis) 01/2018
1	Infections 01/2017
1	Esophagitis 01/2017
1	Tracheoesophageal Fistula 07/2015
1	Liposarcoma 07/2015
1	Gastrinoma 07/2015
1	Meckel Diverticulum 08/2014
1	Melena 10/2007
1	Adenoma (Adenomas) 10/2007
1	Hematemesis 10/2007
1	Celiac Disease (Celiac Sprue) 10/2003
1	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 01/2002

Drug/Important Bio-Agent (IBA)

4	ThrombomodulinIBA 02/2023 - 09/2015
3	Dacarbazine (DIC)FDA LinkGeneric 02/2023 - 09/2015
3	Proton Pump InhibitorsIBA 01/2021 - 01/2017
2	Lubiprostone FDA Link 01/2021 - 01/2021
2	Capsules (Microcapsules)IBA 12/2020 - 08/2014
2	Z 338IBA 01/2019 - 01/2015
2	1- (5- (2- fluorophenyl)- 1- (pyridin- 3- ylsulfonyl)- 1H- pyrrol- 3- yl)- N- methylmethanamineIBA 01/2019 - 01/2017
2	AcidsIBA 01/2018 - 01/2017
1	Formaldehyde (Formol)FDA Link 05/2022
1	elobixibatIBA 01/2021
1	Apolipoprotein A-II (Apolipoprotein A2)IBA 09/2020
1	ApolipoproteinsIBA 09/2020
1	Biomarkers (Surrogate Marker)IBA 09/2020
1	Hyaluronic Acid (Hyaluronan)IBA 04/2020
1	Hemostatics (Antihemorrhagics)IBA 04/2020
1	Lidocaine (Xylocaine)FDA LinkGeneric 04/2020
1	CeruletideIBA 11/2018
1	Chemokine CXCL16IBA 11/2018
1	CytokinesIBA 11/2018
1	ChemokinesIBA 11/2018
1	Cytochrome P-450 CYP2C19IBA 01/2017
1	PotassiumIBA 01/2017
1	CalciumIBA 07/2015
1	Sodium Pertechnetate Tc 99m (Pertechnetate)FDA Link 08/2014
1	Technetium-99IBA 08/2014
1	macroamylaseIBA 10/2003
1	Glutens (Glutelin)IBA 10/2003
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 01/2002

Therapy/Procedure

2	Ligation 12/2020 - 04/2020
2	Therapeutics 01/2019 - 01/2002
1	Surgical Instruments (Clip) 04/2020
1	Sclerotherapy 04/2020
1	Heavy Ion Radiotherapy 07/2015
1	Pancreatectomy 10/2007